Answers are grounded in this paper and cite their sources.
Demonstrating that prophylactic aspirin safely reduces the risk of CVD or cancer in the primary prevention setting, or that omega-3 FA supplementation prevents CVD, would be relevant to hundreds of millions of people worldwide who are currently not receiving such therapies. The results of ASCEND will be reported in 2018.
No takes yet. Share an insight, caveat, or question.
Bowman et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: